Інтелектуальні Фонди БДМУ

Pathogenetic substantiation to correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liverdiseases and disorders of thyroid homeostasis

Показати скорочений опис матеріалу

dc.contributor.author Chympoy, K.A.
dc.contributor.author Pashkovska, N.V.
dc.contributor.author Fediv, O.I.
dc.contributor.author Pavlibroda, N.M.
dc.date.accessioned 2016-05-26T09:35:39Z
dc.date.available 2016-05-26T09:35:39Z
dc.date.issued 2014
dc.identifier.uri http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/10884
dc.description.abstract The dynamics of the indices of fibrinolysis and cellular adhesion in patients with chronic diffuse liver diseases against the ground of administration of “Triovit”, a selenium-containing drug, has been studied. The administration of “Triovit” in a comprehensive therapy of patients with chronic diffuse liver diseases was found to improve the indices of the blood plasma fibrinolytic system, to reduce adhesive cellular properties and to increase total enzymatic activity of the blood plasma. ru_RU
dc.language.iso en ru_RU
dc.publisher Буковинський медичний вісник. – 2014. – Т.18, №2(70). – C.113-116. ru_RU
dc.subject chronic diffuse liver diseases ru_RU
dc.subject cellular adhesion ru_RU
dc.subject fibrinolysis ru_RU
dc.subject Triovit ru_RU
dc.subject хронические диффузные заболевания печени ru_RU
dc.subject тиреоидный гомеостаз ru_RU
dc.subject клеточная адгезия ru_RU
dc.subject фибринолиз ru_RU
dc.subject триовит ru_RU
dc.subject thyroid homeostasis ru_RU
dc.subject хронічні дифузні захворювання печінки ru_RU
dc.subject тиреоїдний гомеостаз ru_RU
dc.subject клітинна адгезія ru_RU
dc.subject фібриноліз ru_RU
dc.subject триовіт ru_RU
dc.title Pathogenetic substantiation to correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liverdiseases and disorders of thyroid homeostasis ru_RU
dc.type Article ru_RU


Долучені файли

Даний матеріал зустрічається у наступних фондах

Показати скорочений опис матеріалу